Analytical Data
-
Gene name
PRADC1
-
简介
PRADC1 Protein, Human (HEK293, His) is a recombinant human protease-associated domain-containing 1 (PRADC1) produced in HEK293 cells, with His tag. PRADC1 is a metabolic-responsive secretory protein that modulates physical activity and adiposity[1].
- Application
-
Alternative Names
rHuPRADC1, His; Protease-associated domain-containing protein 1; PRADC1; C2orf7
-
Species
Human
-
Source
HEK293
-
Tag
C-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BSG0
-
Expression Region
H22-W188
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
28 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PRADC1, or "PR domain containing 1," is a protein that has garnered significant attention in recent years due to its potential roles in various biological processes, including cell proliferation, differentiation, and development. This protein belongs to a family characterized by the presence of a PR domain, which is implicated in gene regulation and chromatin remodeling. Research has indicated that PRADC1 may play a critical role in embryonic development and is essential for normal cellular function. Abnormal expression of PRADC1 has been associated with several diseases, including cancer, making it a focal point for therapeutic research. The recombinant protein version of PRADC1 allows for detailed investigations into its structure, function, and mechanisms of action. By studying the recombinant PRADC1, researchers can elucidate its interactions with other biomolecules, understand its regulatory pathways, and explore its potential as a biomarker or therapeutic target in diseases. These studies contribute to a broader understanding of PRADC1's role in health and disease, ultimately paving the way for novel treatment strategies and interventions.
